- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- Missouri hospital names interim chief administrative officer
- OSF taps foundation president
- Morgan Medical Center launches cardiology service line in Georgia
- The hospitals, health systems cutting jobs in 2026
- Nevada expands Medicaid dental benefits for adults
- 2 dead in Missouri hospital shooting
- New Mexico dentist fined $320K for violating Controlled Substances Act
- Ketamine: 5 notes for behavioral health leaders
- 60 statistics on hospital expenses in mid-2026
- Judge dismisses Stryker cyberattack lawsuit; plaintiffs could refile
- 42 hospitals closing departments or ending services
- Oklahoma surgeon completes world’s 1st knee procedures with Lantern ASC system
- The colonoscopy reimbursement cut GI ASCs didn’t see coming
- Aspen Dental to open Alabama office
- Anthropic’s biggest healthcare bets: 6 key moves
- Mental health admissions averaged $15.9K in total costs: 5 things to know
- DSOs target de novo practices: 7 updates
- 50+ dental executives on the move in the 1st half of 2026
- Gender ratio of nurse practitioners across 50 states
- Palomar Health, UC San Diego Health finalize JPA, form new system
- 6 DSOs making headlines
- 7 new psychiatric residency programs to know
- The ASC cost crisis, by specialty
- US Heart and Vascular expands network with 2 cardiology practice partnerships
- The states losing anesthesiology residents fastest
- 5 mergers, acquisitions in June
- South Carolina behavioral health agency cuts 47 filled positions
- U of Rochester Medical center taps GI surgery chief
- DEA moves to schedule synthetic kratom compound
- The newest weapon against insurer nonpayment — and its growing controversy
- CMS wants power to remove ‘problematic’ physicians, ASCs from Medicare
- Physician practice owner to pay $1.5M to resolve false claims allegations
- 5 DSOs that dominated Q2
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- The missing piece in crisis care? A model that avoided 1,580 ED days
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
Michigan healthcare freedom community forum
At least it is not tax dollars at work; only the proceeds of lawfare. MDHHS is funding an opioid Harm Reduction strategy, many components of which violate local ordinances - not to mention sanity:
Community ordinances are clashing with Michigan’s drug harm reduction strategy
By Georgea Kovanis - May 13, 2024When it comes to trying to reduce the devastation that accompanies the use of illicit drugs, experts say Michigan is working against itself.
Here's what's happening: In an effort to keep people alive, the state of Michigan is funneling millions of dollars from settlements with opioid manufacturers and distributors into a strategy called harm reduction — reducing the harms associated with drug use. That means easy access to Narcan, which can reverse an opioid overdose if given quickly and correctly. It also means reducing the spread of infectious disease by providing clean syringes to intravenous drug users. And it means providing kits to test drugs for the presence of ultra-deadly fentanyl in street drugs.
At the same time, hundreds of local communities have paraphernalia ordinances that prohibit people from possessing or providing syringes and other supplies, including kits to test for the presence of fentanyl in street drugs. What's legal in one community may be illegal in another.
Harm reduction advocates say the local laws are compromising their efforts and punishing drug users who are trying to do what health officials advise.
"We're basically criminalizing people trying to protect their health and protect the community's health," said Steve Alsum, executive director of the Grand Rapids Red Project, a prominent harm reduction agency in west Michigan that supplies syringes and test kits. Syringe services programs "could provide more benefit to more of the community if these programs were legal state wide."
So what does this clash of laws and philosophies really mean?
And why does it matter to people who don't use drugs?
Back up, drug users can get free needles?
They can — and they can get more than that.
A variety of syringe service programs across the state, including ACCESS in Sterling Heights, the Red Project, and Harm Reduction Michigan in northern Michigan and the Families Against Narcotics' Harm:Less mobile unit, use opioid settlement money to supply needles and other harm reduction equipment to drug users.
Among those supplies: Kits to determine whether drugs contain fentanyl, the synthetic opioid that is involved in the majority of the nation's 100,000-plus overdose deaths a year, including roughly 3,000 in Michigan.
And, kits to test drugs for xylazine, a potent, non-opioid large animal tranquilizer that is most often mixed into fentanyl. Last year, Oakland County Sheriff Michael Bouchard said xylazine was present in up to 85% of the fentanyl his department seized. Because it is not an opioid, xylazine is impervious to Narcan.
To find a complete list of syringe service programs, go to rb.gy/osre70
How many needles are we talking about here?
We're talking about more and more syringes every year.
In the fourth quarter of 2023, syringe service programs across the state distributed nearly 1.2 million syringes, a 30% increase compared with the fourth quarter of 2022, accoridng to data from the Michigan Department of Health and Human Services (MDHHS).
So these syringe service programs help addicts do drugs?
They recognize the reality of drug addiction, advocates say.
Addicts are going to use whether or not they have access to clean needles; that's the nature of addiction. Shared needles promote the spread of HIV and Hepatitis C. Reusing needles promotes endocarditis, an infection that inflames the lining of the heart's valves and chambers.
According to the U.S. Centers for Disease Control and Prevention, people who participate in a syringe service program lower their risk of contracting HIV or Hepatitis C by 50%.
“Most people who inject drugs, if they have access to sterile, unusued syringes, they're going to use a sterile, unused syringe each and every time they inject," said Alsum. "The reason people share or reuse syringes is there's a lack of access to them caused by the criminalization of that tool."
In addition, research shows people who participate in syringe service programs are five times more likely to seek treatment for their addiciton than are those who do not participate in needle exchange programs.
And because fentanyl and xylazine have infiltrated street drugs, providing kits to test for the presence of those substances, can save lives. They may still use their fentanyl or xylazine-laced drugs, but they may choose to use at a slower pace or choose to use in the presence of someone who can call for help if they overdose.
Not everyone agrees with this approach. Opponents argue that passing out clean needles only enables drug use. Opponents also argue that there's a reason paraphernalia laws are on the books: drugs are dangerous and a menace to society.
A change of leadership in the Eastpointe Police Department shut down the Harm:Less syringe service mobile unit late last year. It had been operating at the intersection of Eight Mile and Gratiot for some time.
Eastpointe Police Chief Corey Haines directed Free Press questions about the decision to City Council.
"We are relying upon the in depth expertise of our Chief of Police to ensure that the health, welfare and safety of our residents, businesses and visitors are prioritized," said Assistant City Manager Kim Homan. "Properties at the Gratiot and 8 Mile Road's intersection reflect an important entrance to our city."
What's so difficult about obeying the law?
When it comes to syringes and other drug paraphernalia, laws aren't consistent.
"Every city has this patchwork of ordinances," said Andrew Coleman, who runs harm reduction programs for ACCESS (the Arab Community Center for Economic and Social Services), which has offices in Sterling Heights and Dearborn.
Sterling Heights, for example, allows syringes and parapheranalia for illicit drug use as long as they are distributed by a recognized health authority with the aim of stopping the spread of innfectious disease. As a result, ACCESS is able to give out syringes in that community.
But Dearborn outlaws the posession and use of all syringes and paraphernalia related to illicit drugs ― even if they come from a legitimate harm reduction agency, which mean ACCESS is not allowed to provide syringes in that city.
Lincoln Park, which has one of the highest rates of drug overdose deaths in the state, also outlaws them. It also considers products designed to test drugs, such as fentanyl test strips, as paraphernalia.
In Flint, which also has one of the highest overdose death rates in the state, it's illegal to give away, furnish or display hypodermic needles or any other device designed or adapted for drug use, although those rules do not apply to participants of the Wellness AIDS Service Incorporated Approved Syringe Exchange Program.
In Detroit, paraphernalia, including syringes and test strips, are illegal unless provided by an authorized syringe exchange program.
So what's legal in one community isn't necessarily legal in another.
The state has a law, too: Selling syringes is illegal, unless they're sold by an agency authorized to reduce the transmission of infectious disease; except those agencies don't sell syringes, they give them away.
“It seems kind of crazy to have really begun to encourage these programs but not have that issue taken care of," said Pam Lynch, director of Harm Reduction Michigan, which is based in Traverse City and Petoskey, but does work throughout the state.
For fiscal year 2024, the state allocated $4.2 million of opioid settlement money for syringe service programs, according to MDHHS.
Why can't people just drive to where paraphernalia is legal and get it there?
They can. But possessing syringes or driving with them in communities where they are not legal can still result in criminal charges.
In most cases the maximum punishment is a $500 fine and/or 90 days in jail.
But for someone who is already on probation, an additional charge can mean a probation violation, which can result in more sanctions.
In addition, harm reduction workers who distribute the syringes or other outlawed paraphernalia could be charged with possessing or supplying contraband.
And Lynch pointed to another issue:
Syringe service programs also dispose of used syringes. Used syringes contain residue or small amounts of illicit drugs and having one of those could lead to a drug posession charge.
As a result, Lynch said, drug users "are disincentivized to return used syringes … they're disincentivized to take those public health measures. … By people not being able to use sterile equipment to prevent disease and return it safely, (the state is) kind of working against itself."
I don't do drugs, why should care about this?
There's the humanitarian aspect.
But there's also the financial aspect.
"The longer term, the bigger picture outcomes of paraphernalia ordinances are increased services at emergency departments, increased services for HIV," said Lynch.
From 2002-2012, U.S. hospitalizations for drug-related infections cost more than $700 million a year, according to research cited by the CDC. And that was before, the opioid epidemic and the intravenous drug use that it fostered reached fever pitch.
The most common payer for those hospitalizations: Medicaid, which is partly funded by state taxpayers.
Meanwhile, in 2017, opioid addiction alone cost the United States $1 trillion in health care, treatment, incarceration, lost productivity and reduced quality of life, according to the CDC.
Will the state make its rules consistent across Michigan?
Last year, state Rep. Carrie Rheingans, D-Ann Arbor, introduced a pair of bills that, if passed by Lansing lawmakers and signed by Gov. Gretchen Whitmer, would alleviate the concerns of harm reduction advocates.
House Bill 5178 would decriminalize the posession or distribution of needles, hypodermic syringes or drug paraphernalia aimed at reducing the spread of infectious disease by who those who work at legitimate syringe exchange programs and for those who participate in them. The bill would also decriminalize controlled substance contained in a used needle, hypodermic or drug paraphernalia if the amount of the substance is an amount sufficient only for personal use. The rules set forth in the bill would supercede all local ordinances.
House Bill 5179 would legalize products used to determine whether a controlled substance includes adulturants, including but not limited to fentanyl kits.
Rheingans, who holds dual master's degrees in public health and social work, had previously worked in HIV outreach and needle exchange.
“People in the general public and my colleagues look at it as a way to let people keep using and injecting drugs." she said. "People don’t understand that it’s a good public health measure.”
Two questions:
1) What plans are there to safely dispose of the annual 5 million sharps across Michigan? Will they pave the streets and sidewalks of Michigan? This amount of randomly discarded medical waste should make a great Pure Michigan ad.
2) When do diabetics get free needles? They seem like a deserving group.
Question 2 is a good one - diabetics have a bona fide medical condition; drug addicts start out with a choice to do something harmful.
I truly believe these programs enable drug use by providing drug users with the supplies they need.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















